Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eastman Chemical (EMN) Research & Development (2016 - 2025)

Eastman Chemical (EMN) has disclosed Research & Development for 17 consecutive years, with $58.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 12.12% year-over-year to $58.0 million, compared with a TTM value of $255.0 million through Dec 2025, up 2.0%, and an annual FY2025 reading of $255.0 million, up 2.0% over the prior year.
  • Research & Development was $58.0 million for Q4 2025 at Eastman Chemical, down from $63.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $68.0 million in Q3 2022 and bottomed at $57.0 million in Q4 2023.
  • Average Research & Development over 5 years is $63.1 million, with a median of $63.5 million recorded in 2021.
  • The sharpest move saw Research & Development rose 21.15% in 2021, then decreased 12.12% in 2025.
  • Year by year, Research & Development stood at $67.0 million in 2021, then decreased by 4.48% to $64.0 million in 2022, then fell by 10.94% to $57.0 million in 2023, then rose by 15.79% to $66.0 million in 2024, then fell by 12.12% to $58.0 million in 2025.
  • Business Quant data shows Research & Development for EMN at $58.0 million in Q4 2025, $63.0 million in Q3 2025, and $67.0 million in Q2 2025.